Literature DB >> 24334803

Active surveillance for carbapenem-resistant Enterobacteriaceae using stool specimens submitted for testing for Clostridium difficile.

David B Banach1, Jeannette Francois, Stephanie Blash, Gopi Patel, Stephen G Jenkins, Vincent LaBombardi, Barry N Kreiswirth, Arjun Srinivasan, David P Calfee.   

Abstract

Active surveillance to identify asymptomatic carriers of carbapenem-resistant Enterobacteriaceae (CRE) is a recommended strategy for CRE control in healthcare facilities. Active surveillance using stool specimens tested for Clostridium difficile is a relatively low-cost strategy to detect CRE carriers. Further evaluation of this and other risk factor-based active surveillance strategies is warranted.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24334803      PMCID： PMC3984911          DOI： 10.1086/674391

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  9 in total

1.  Undetected vancomycin-resistant Enterococcus stool colonization in a Veterans Affairs Hospital using a Clostridium difficile-focused surveillance strategy.

Authors:  Amy J Ray; Claudia K Hoyen; Sarbani M Das; Elizabeth C Eckstein; Curtis J Donskey
Journal:  Infect Control Hosp Epidemiol       Date:  2002-08       Impact factor: 3.254

2.  Multiplex PCR for detection of acquired carbapenemase genes.

Authors:  Laurent Poirel; Timothy R Walsh; Vincent Cuvillier; Patrice Nordmann
Journal:  Diagn Microbiol Infect Dis       Date:  2011-03-12       Impact factor: 2.803

3.  Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures.

Authors:  D Landman; J K Salvani; S Bratu; J Quale
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity.

Authors:  Mahesh Swaminathan; Saarika Sharma; Stephanie Poliansky Blash; Gopi Patel; David B Banach; Michael Phillips; Vincent LaBombardi; Karen F Anderson; Brandon Kitchel; Arjun Srinivasan; David P Calfee
Journal:  Infect Control Hosp Epidemiol       Date:  2013-06-11       Impact factor: 3.254

5.  Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection.

Authors:  Debby Ben-David; Yasmin Maor; Nathan Keller; Gili Regev-Yochay; Ilana Tal; Dalit Shachar; Amir Zlotkin; Gill Smollan; Galia Rahav
Journal:  Infect Control Hosp Epidemiol       Date:  2010-06       Impact factor: 3.254

6.  High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.

Authors:  Frank M Kaczmarek; Fadia Dib-Hajj; Wenchi Shang; Thomas D Gootz
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

7.  Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolates in faecal samples of broilers.

Authors:  Daniela Costa; Laura Vinué; Patricia Poeta; Ana Cláudia Coelho; Manuela Matos; Yolanda Sáenz; Sergio Somalo; Myriam Zarazaga; Jorge Rodrigues; Carmen Torres
Journal:  Vet Microbiol       Date:  2009-03-28       Impact factor: 3.293

8.  Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies.

Authors:  Gopi Patel; Shirish Huprikar; Stephanie H Factor; Stephen G Jenkins; David P Calfee
Journal:  Infect Control Hosp Epidemiol       Date:  2008-12       Impact factor: 3.254

9.  Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.

Authors:  Mitchell J Schwaber; Shiri Klarfeld-Lidji; Shiri Navon-Venezia; David Schwartz; Azita Leavitt; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191
  9 in total
  5 in total

1.  Biographical Feature: Stephen G. Jenkins, Ph.D., D(ABMM), F(AAM).

Authors:  Alexander J McAdam
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

2.  Evaluation of Remel Spectra CRE Agar for Detection of Carbapenem-Resistant Bacteria from Rectal Swabs Obtained from Residents of a Long-Term-Care Facility.

Authors:  Vincent J LaBombardi; Carl M Urban; Barry N Kreiswirth; Liang Chen; Giuliana Osorio; Joanna Kopacz; Georges Labaze; Sorana Segal-Maurer
Journal:  J Clin Microbiol       Date:  2015-06-17       Impact factor: 5.948

3.  The pros, cons, and unknowns of search and destroy for carbapenem-resistant enterobacteriaceae.

Authors:  Prashini Moodley; Andrew Whitelaw
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

4.  Active Surveillance of Carbapenemase-Producing Organisms (CPO) Colonization With Xpert Carba-R Assay Plus Positive Patient Isolation Proves to Be Effective in CPO Containment.

Authors:  Menglan Zhou; Timothy Kudinha; Bin Du; Jinmin Peng; Xiaojun Ma; Yang Yang; Ge Zhang; Jingjia Zhang; Qiwen Yang; Ying-Chun Xu
Journal:  Front Cell Infect Microbiol       Date:  2019-05-14       Impact factor: 5.293

5.  Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.

Authors:  Thomas Howe McConville; Sean Berger Sullivan; Angela Gomez-Simmonds; Susan Whittier; Anne-Catrin Uhlemann
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.